717-1446

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
717 (USA) · Dr. Reyes
consented 2013-09-01

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-15 (study day 15.0); relationship: POSSIBLE

mild assessed

Mild ANXIETY — outcome: RECOVERED/RESOLVED; onset 2013-09-15 (study day 15.0); relationship: POSSIBLE

moderate assessed

Moderate PAIN — outcome: RECOVERED/RESOLVED; onset 2014-01-13 (study day 135.0); relationship: PROBABLE

moderate assessed

Moderate PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-28 (study day 150.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-07 (study day 37.0); relationship: REMOTE

mild assessed

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-10-07 (study day 37.0); relationship: REMOTE

mild assessed

Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-06 (study day 36.0); relationship: REMOTE

mild assessed

Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-10-06 (study day 36.0); relationship: REMOTE

moderate assessed

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-19 (study day 19.0); relationship: POSSIBLE

Data queries

No data queries.